Personalised therapy for Follicular Lymphoma: Exploring mTORC1 activating RRAGC and v ATPase mutations as biomarkers of response to Temsirolimus

Gender
Any

Age Group
Any

At a Glance

IRB#IRB17-0225

Lead PhysicianSonali Smith

Collaborator(s)N/A

EligibilityNot Recruiting